Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03648489 |
| Consolidated Lead Sponsor | Imperial College London |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 134 participants (ACTUAL) |
| Registered Start Date | 2018-09-21 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Charité Universitätsmedizin Berlin | Berlin, Germany | Open Hospital Dossier -> |
| The Royal Marsden NHS Foundation Trust | London, United Kingdom | Open Hospital Dossier -> |
| Imperial College Healthcare NHS Trust | London, United Kingdom | Open Hospital Dossier -> |
| The Christie NHS Foundation Trust | Manchester, United Kingdom | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.